 
|
fonemed.com |
|
|
|
|
|
|
|
|
FONEMED Joins Forces With Cyber-Care National Call Center Enhances Access to Around-the-Clock Medical Information With Electronic HouseCall Family of Products
BOYNTON BEACH, FL--(BW HealthWire)--June 26, 2001 - Cyber-Care, Inc. (Nasdaq:CYBR - news) today executed a Letter of Intent with FONEMED® to utilize the CyberCare System(TM) to enhance the medical services currently provided by its national call center. FONEMED uses communications technology to provide individuals with around-the-clock telephone or Web-based access to medical advice, information, products, and services through its North American call center. The CyberCare System(TM), which includes Electronic HouseCall® (EHC(TM)) family of products, the CyberCare 24 Network(TM) and the Cyber HealthManager(TM), will be used to monitor patients managed at home while under FONEMED's watch. An initial deployment of up to ten EHC units (EHC models 100, 350, and 600) is planned to begin in July to fully test integration and operation considerations before a national roll-out. It is anticipated the initial phase will last 90 days. At the successful conclusion of the initial roll-out, FONEMED plans to deploy a minimum of 100 EHC units. "Our alliance with Cyber-Care opens a new era in telehealth,'' said Ken Bleakley, president and CEO of FONEMED. "It gives Registered Nurses in our URAC-accredited medical call center the best monitoring systems available to better manage and advise patients - remotely - 24 hours a day.'' Bleakley added "With the EHC family of products, RNs will be able to remotely measure and monitor patient vitals signs such as: blood pressure, heart and lung sounds, blood oxygen levels, blood sugar levels, body temperature, pulse, and body weight.'' According to Mike Lemnitzer, vice president of business development for Cyber-Care, the addition of EHC products and services to FONEMED's current operations and services offers a perfect match. "Over the past several years, FONEMED has clearly demonstrated that patients can effectively be monitored remotely,'' Lemnitzer said. ``Now, by adding Cyber-Care's products and services to its service offerings, FONEMED has raised the performance standards for how patients should be monitored.'' About Cyber-Care, Inc. Cyber-Care, Inc. is a network-based telehealth solutions company improving the delivery of care through its Internet-based technology. Cyber-Care creates a live, interactive community that incorporates all members of the care team in the healthcare delivery process, resulting in cost reduction and improvement in the quality of patient care. Utilizing patented technology for remote monitoring and real-time interactive communications between chronically ill patients and their providers, Cyber-Care's System allows for effective and efficient data collection, case management and personal interaction. Headquartered in Boynton Beach, Fla., Cyber-Care also has physical, occupational and speech therapy businesses and an institutional pharmacy. Visit Cyber-Care's Web site at http://www.cyber-care.net. About FONEMED FONEMED® uses communications technology to provide individuals with round-the-clock, telephone or web-based access to medical advice, information, products, and services. It provides outsourced services from its North American call center, accredited by the American Accreditation HealthCare Commission/URAC. It also supplies qualified partners with the tools, technology, and know-how to operate proprietary Health Information Centers as either installed systems (for internal use only) or with concession agreements (for specified geographic locations). For more information, visit http://www.fonemed.com or call 1-800-FONEMED. Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements which are not historical facts contained in this press release are forward-looking statements that involve certain risks and uncertainties including but not limited to risks associated with the uncertainty of future financial results, additional financing requirements, development of new products, product acceptance and effectiveness, government approval processes, the impact of competitive products or pricing, technological changes, the effect of economic conditions and other uncertainties detailed in the Company's filings with the Securities and Exchange Commission. Contact:
|
|
FONEMED © 2008 |
|